US Patent Issued to ReacX Pharmaceuticals on July 14 for "Implantable devices for drug delivery with reduced burst release" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,401, issued on July 14, was assigned to ReacX Pharmaceuticals Inc. (South San Francisco, Calif.).

"Implantable devices for drug delivery with reduced burst release" was invented by Rajesh A. Patel (South San Francisco, Calif.), Sunil Sreedharan (South San Francisco, Calif.) and Sunil R. Bhonsle (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides implantable drug delivery devices comprising a core comprising a polymer (or polymer blend) and one or more drugs or pharmaceutical substances, and an outer shell comprising a polymer (or polymer blend) and one or more porogen materials. The invention reduces bu...